[Anti-endometrial cancer monoclonal antibody "MSN-1" and its application to EmC-EIA method]

S Nozawa, Nozawa S, Tsukazaki K, K Tsukazaki, Sakayori M, M Sakayori, Y. Kobayashi, Kobayashi Y, Kobiki K, K Kobiki
Rinsho byori. The Japanese journal of clinical pathology · 1993 · PMID:8361005
other public-domain-us
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

This paper describes the anti-endometrial cancer monoclonal antibody MSN-1 and its use in developing an endometrial cancer enzyme immunoassay (EmC-EIA) method.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

DNA-Binding Proteins Endometrial Neoplasms Immediate-Early Proteins Antibodies, Monoclonal DNA-Binding Proteins DNA-Binding Proteins Endometrial Neoplasms Endometriosis Endometriosis Female Humans Hypoxia-Inducible Factor-Proline Dioxygenases Immunoenzyme Techniques Immunoglobulin M Procollagen-Proline Dioxygenase Risk

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-04T09:26:46.659050+00:00
pubmed
last seen: 2026-05-13T22:11:39.448046+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine